Pharmacology of new antimalarial drugs: three guanylhydrazones.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001577:Benzophenones / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002725:Chloroform; D004285:Dogs; D004562:Electrocardiography; D006147:Guanine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology*; D008170:Lung Compliance / Q000187:drug effects; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D011651:Pulmonary Artery / Q000187:drug effects; D051381:Rats; D014655:Vascular Resistance / Q000187:drug effects
D000962:Antimalarials; D001577:Benzophenones; D006834:Hydrazines; D006147:Guanine; D002725:Chloroform